 |
| Invirion Launches First Quantitative HPV E6, E7 Assay and Announces CE Mark and Approval for Reimbursement in Spain More |
|
Invirion Diagnostics, LLC Announces Release of Newest Reagent Kit
More |
| Dr. Bruce Patterson, Founder of Invirion, presented “Viral Diagnostic Assays Using Flow Cytometry” in a Plenary session of the Clinical Virology Symposium, Clearwater, FL May 2006. |
| Invirion, Inc. Forms Strategic Partnership with Worldwide AIDS Coalition (WWAC) In Fight Against HIV/AIDS in Africa More | |
| is the first theranostics company dedicated to the detection, monitoring and treatment of life-threatening viral diseases such as HIV/AIDS, cervical cancer, and organ transplant rejection. Invirion, Inc. was founded in 1999 with the goal of commercializing state-of-the-art molecular virology technology to make a difference in people’s lives. Invirion’s research, development, and commercialization efforts are focused on monitoring viruses that cause human disease and using the information gleaned from these novel assays to develop therapeutic products that rationally target the viral lifecycle. |
|
